Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    10471456 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
Condition: ST-elevation Myocardial Infarction
Interventions: Drug: Mineralocorticoid receptor antagonist potassium-canrenoate;   Drug: placebo
2 Completed
Has Results
PIE II: Pharmacological Intervention in the Elderly II
Conditions: Diastolic Heart Failure;   Heart Failure, Congestive
Interventions: Drug: Spironolactone;   Drug: Placebo
3 Recruiting Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
Conditions: Renal Insufficiency, Chronic;   Cardio-Renal Syndrome
Interventions: Drug: Spironolactone;   Drug: Chlortalidone
4 Not yet recruiting Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
Conditions: Hypertrophic Cardiomyopathy;   Fibrosis
Intervention: Drug: Spironolactone
5 Unknown  Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy;   Coronary Artery Disease;   Myocardial Diseases
Intervention: Device: Blue Egg Device
6 Completed Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Conditions: Chronic Kidney Disease;   Cardiovascular Disease
Interventions: Drug: Spironolactone;   Drug: Placebo
7 Completed Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
Condition: Congestive Heart Failure, Atrial Fibrillation
Intervention: Device: Vitatron biventricular pacemaker

Study has passed its completion date and status has not been verified in more than two years.